What specific problem does LucidAct solve?

Based on slides 3 and 7, LucidAct addresses the administrative burden and clinician burnout associated with chronic care management. The product appears to automate the tracking of patient tasks, such as checking eligibility for Catherine Aagard or sending Annual Wellness Visit (AWV) reminders for Chrissy Abbott, which are critical for capturing Medicare reimbursements.

Who is the target customer for this AI assistant?

Slide 12 explicitly states the target market is 'Medium to Large Health Care Customers.' The inclusion of logos like Sutter Health and Stanford Health Care under the team's experience (Slide 14) suggests the company is pursuing enterprise-level health systems rather than small private practices.

How does LucidAct generate value for healthcare providers?

The deck implies a financial link between Medicare and hospital revenue (Slide 2). By using an AI assistant to manage chronic care tasks (Slide 7), providers can presumably ensure they meet the documentation and follow-up requirements necessary to trigger Medicare payments more efficiently and with less manual labor.

What is the technical composition of the founding team?

The team is technically robust, featuring a CTO (Cheong Ang) with a background at UCSF Health and IBM, a VP of Engineering (USS Uppuluri) from Cognizant, and a Data Scientist (Victor Fang) with experience at Awake and Pivotal. This suggests a focus on data-heavy, enterprise-grade software development.

Is there a clear business model or pricing strategy in the deck?

No. The provided slides do not include information on pricing tiers, subscription models, or unit economics. The deck is designed for a Demo Day format, which typically prioritizes the problem, solution, and team over granular financial modeling.

LucidAct Pitch Deck: 14-Slide Seed Deck

See all 14 slides of the LucidAct pitch deck — a Healthcare AI deck — with a slide-by-slide teardown of what the deck does well and where it falls short.

LucidAct’s Batch 25 Demo Day deck is a study in minimalist presentation design, intended to support a live spoken pitch rather than serve as a standalone document. The company positions itself as an AI-driven solution for chronic care management, specifically tapping into Medicare-funded workflows. While the deck lacks explicit financial projections, market sizing, or a specific investment ask in the provided slides, it leans heavily on the professional pedigree of its founding team, which includes alumni from Stanford Health Care, IBM, and UCSF Health. The visual narrative moves from the mac…

Key takeaways

The deck identifies Medicare as the primary economic driver for healthcare providers using the platform (Slide 2).
Clinician burnout and administrative stress are framed as the central emotional and operational problems (Slide 3).
The product interface focuses on task automation, specifically tracking patient eligibility and wellness visit reminders (Slide 7).
The solution incorporates an automation layer, represented by robotic arms interacting with a digital interface (Slide 9).
The company targets 'Medium to Large Health Care Customers,' though specific names were redacted or omitted in the provided view (Slide 12).
The founding team possesses significant domain expertise, citing experience at Sutter Health, Stanford Health Care, and UCSF Health (Slide 14).
Technical depth is highlighted through team backgrounds at IBM, Cognizant, and Intuit (Slide 14).
The deck lacks standard venture metrics such as TAM/SAM/SOM, CAC/LTV, or a clear funding ask in the seven slides provided.

LucidAct Pitch Deck Analysis

The LucidAct Batch 25 Demo Day deck is a highly visual, low-text presentation typical of the 500 Startups or Y Combinator demo day formats. With only 14 slides total (7 provided for this analysis), the deck is designed to be a backdrop for a high-energy, two-minute spoken pitch. It focuses on the 'Who' and the 'What,' leaving the 'How Much' for follow-up conversations.

Slide 1: Title Slide

The deck opens with a clear value proposition: 'LucidAct AI Assistant for Chronic Care Management.' It identifies Cheong Ang as the Co-founder and provides a direct contact email. The imagery of two nurses reviewing a tablet reinforces the clinical setting and the collaborative nature of the tool. The branding is consistent, using a green and blue palette that evokes health and technology.

Slide 2: The Economic Driver

This slide uses iconography to establish the market's financial foundation. It shows the Medicare logo transitioning into a hand holding a dollar sign, which then points to a hospital building. This is a shorthand way of telling investors that the company operates in a space where government spending (Medicare) is the primary source of revenue for their customers (hospitals). It suggests that LucidAct helps hospitals capture or protect this specific revenue stream.

Slide 3: The Emotional Problem

Slide 3 is a full-bleed image of a clinician in scrubs, head in hand, appearing exhausted or stressed. In a pitch, this serves as the 'Problem' slide. It highlights the burnout crisis in healthcare, specifically the administrative overhead that prevents doctors and nurses from focusing on patient care. By not using text, the founder forces the audience to listen to the narrative of why current systems are failing staff.

Slide 7: Product Interface and Task Management

This slide provides a look at the actual software. The 'My Tasks' dashboard shows a list of patients (e.g., Catherine Aagard, Chrissy Abbott) with specific actionable items. The tasks listed—'Check eligibility,' 'Send AWV reminder,' and 'Go over results with patient'—indicate that LucidAct is a workflow automation tool. It tracks patient details, last update dates, and specific comments, acting as a specialized CRM for chronic care management.

Slide 9: The Automation Concept

Slide 9 uses a metaphorical illustration: robotic arms surrounding a computer screen featuring the LucidAct logo. This represents the 'AI' and 'Automation' aspect of the assistant. It communicates that the software isn't just a passive database but an active agent that performs tasks (represented by the gears and clocks) to save time for the human users shown in Slide 3.

Slide 12: Target Market

The heading 'Medium to Large Health Care Customers' defines the company's Sales Development Representative (SDR) focus. The slide contains six empty placeholders, which in a live presentation might have been populated with pilot partners or a pipeline of prospects. As presented here, it serves to define the scale of the enterprise LucidAct is built to serve.

Slide 14: Team Pedigree

The team slide is the strongest part of the deck in terms of establishing credibility. It lists five key members: Grace Chen (CEO), Cheong Ang (CTO), USS Uppuluri (VP Engr), Sridhar Gudimela (Engineer), and Victor Fang (Data Scientist). The logos beneath them—Sutter Health, Stanford Health Care, UCSF Health, IBM, Cognizant, and Intuit—demonstrate a mix of deep clinical domain expertise and high-level enterprise software engineering. This is a 'heavyweight' team for an early-stage startup, which is a significant signal to investors.

What Works in This Deck

Visual Storytelling: The deck avoids the common pitfall of 'death by bullet point.' By using evocative imagery (the stressed nurse) and clear icons (the Medicare flow), the founders can maintain eye contact with the audience while the slides provide context.

Clear Persona: The product slide (Slide 7) makes it very clear who uses the tool and what they do with it. It isn't a vague 'AI for health' pitch; it is a 'Task manager for AWV reminders and eligibility' pitch.

Team-Market Fit: The team's background at major California health systems (Stanford, UCSF, Sutter) suggests they understand the specific bureaucratic and technical hurdles of selling into large hospitals.

What is Missing

Market Sizing (TAM): There is no mention of how many 'Medium to Large' hospitals exist or what the total addressable revenue from Medicare chronic care management might be. Investors need to know if this is a billion-dollar opportunity or a niche tool.

Business Model: The deck does not explain how LucidAct makes money. Is it a per-provider SaaS fee? A percentage of the Medicare reimbursement captured? A per-patient-per-month (PPPM) model?

Competition: The healthcare AI space is crowded. The deck does not address how LucidAct differs from existing Electronic Health Record (EHR) features or other AI assistants like Olive or Notable Health.

Traction: While Slide 12 mentions customers, there are no specific metrics regarding current revenue, number of patients managed, or pilot results. Even in a demo day deck, a single 'traction' slide with growth percentages is standard.

Founder Takeaways

Design for the Venue: If you are pitching on a stage where you have less than three minutes, follow LucidAct's lead: use large images and minimal text. Save the spreadsheets for the data room. · Leverage Logos: If your team has worked at prestigious institutions, put those logos front and center. In healthcare, 'who you know' and 'where you've been' are often as important as the code you've written. · Identify the Payer: LucidAct correctly identifies Medicare as the ultimate payer. In US healthcare, if you can't show how your tool leads to a reimbursement or a cost saving for a specific payer, you don't have a business. · Show the 'Work': Slide 7 is effective because it shows the actual work being done. Founders often show 'vision' slides but forget to show the 'utility' slides. Showing a list of tasks makes the AI feel real and useful.

Frequently asked questions

What specific problem does LucidAct solve?: Based on slides 3 and 7, LucidAct addresses the administrative burden and clinician burnout associated with chronic care management. The product appears to automate the tracking of patient tasks, such as checking eligibility for Catherine Aagard or sending Annual Wellness Visit (AWV) reminders for Chrissy Abbott, which are critical for capturing Medicare reimbursements.
Who is the target customer for this AI assistant?: Slide 12 explicitly states the target market is 'Medium to Large Health Care Customers.' The inclusion of logos like Sutter Health and Stanford Health Care under the team's experience (Slide 14) suggests the company is pursuing enterprise-level health systems rather than small private practices.
How does LucidAct generate value for healthcare providers?: The deck implies a financial link between Medicare and hospital revenue (Slide 2). By using an AI assistant to manage chronic care tasks (Slide 7), providers can presumably ensure they meet the documentation and follow-up requirements necessary to trigger Medicare payments more efficiently and with less manual labor.
What is the technical composition of the founding team?: The team is technically robust, featuring a CTO (Cheong Ang) with a background at UCSF Health and IBM, a VP of Engineering (USS Uppuluri) from Cognizant, and a Data Scientist (Victor Fang) with experience at Awake and Pivotal. This suggests a focus on data-heavy, enterprise-grade software development.
Is there a clear business model or pricing strategy in the deck?: No. The provided slides do not include information on pricing tiers, subscription models, or unit economics. The deck is designed for a Demo Day format, which typically prioritizes the problem, solution, and team over granular financial modeling.

Cover slide of the LucidAct pitch deck — Seed (Batch 25 Demo Day) — LucidAct pitch deck, slide 1

LucidAct pitch deck: the facts

Company: LucidAct
Year: Not stated
Stage: Seed (Batch 25 Demo Day)
Slides: 14
Sector: Healthcare AI / Chronic Care Management
Deck type: Demo Day Pitch Deck
Outcome: Not stated
Headquarters: Not stated

LucidAct pitch deck PDF

The full LucidAct deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the LucidAct Health Inc pitch deck was used for

This deck is a 14‑slide **seed‑stage** presentation for LucidAct used at **Batch 25 Demo Day** in 2019, focused on an AI assistant for chronic care management targeting medium to large healthcare providers. It showcases an AI‑driven virtual care assistant and nurse‑led chronic care service operating under Medicare reimbursement, with early traction figures (patients and nurses) and per‑patient subscription pricing. At the time of the deck, LucidAct was transitioning from trial deployments to paid revenue in a large chronic care and Medicare market, positioning itself as a workflow and reimbursement optimization platform for providers. The deck precedes or coincides with a disclosed $150K seed round completed in October 2019, when the company was already generating revenue.

Business model: Enterprise SaaS and services platform for healthcare organizations, offering AI-powered chronic care management, remote patient monitoring, insurance checklist automation, and virtual care workflows for Medicare/Medicaid and other patients.

Round: Seed
Year: 2019
Raised: $150K total disclosed seed funding.
Investors: Social Starts, 500 Accelerator / 500 Global, Liquid 2 Ventures, StartUp Health
Founded: 2015
Industry: Healthcare technology / Digital health / Enterprise healthcare systems.
Total funding: $150K total disclosed funding

Headquarters: San Francisco Bay Area, California, United States (addresses reported include San Francisco and Santa Clara locations).

What happened after the LucidAct Health Inc deck

Following its Batch 25 Demo Day seed‑stage pitch, LucidAct completed a $150K seed round in October 2019 while already generating revenue, and has continued to operate and evolve its AI‑powered chronic care and remote care platform for healthcare organizations.

Completion of a **seed round** on October 3, 2019, with disclosed funding of **$150K**, at which point the company was c
Ongoing development of an AI‑powered care management platform with features including pre‑built CCM workflows, AI‑based
Establishment of LucidAct as a provider of remote patient monitoring and connected telemedicine solutions for non‑tech‑s
Continuation and expansion of product offerings into a broader virtual care and connected healthcare platform, including

What the LucidAct Health Inc deck got right

Strong early traction and operational scale. The deck presents **concrete traction metrics**, stating that LucidAct launched its AI assistant eight months prior and now manages chronic care for **30,000 patients** using a team of **100 nurses**, which indicates meaningful early adoption and operational scale for a seed‑stage company.
Clear per‑patient subscription pricing. LucidAct clearly articulates a **subscription business model**, charging **$44–$98 per patient per month** and targeting medium to large healthcare customers, allowing investors to quickly estimate revenue potential at scale.
Compelling alignment with a large and growing market. The pitch situates the product within a **large $111B chronic care/Medicare market**, emphasizing value in navigating complex reimbursement and workflow challenges for providers, which aligns well with macro trends in value‑based care.
Differentiated AI‑driven workflow automation. By emphasizing an **AI assistant for chronic care management** and workflow automation around eligibility checks, forms, and patient outreach, the deck highlights a differentiated technology layer on top of care team operations.
Credible human‑plus‑AI care delivery model. The visual focus on team experience and nurse‑led services in chronic care and Medicare contexts underscores LucidAct’s **human‑in‑the‑loop care model**, which can reassure investors about real‑world applicability and clinical feasibility compared with purely software‑based solutions.
External validation through reputable accelerators and investors. Participation in **Batch 25 Demo Day** and the presence of later‑reported seed investors such as Social Starts, 500, Liquid 2 Ventures, and StartUp Health provide external validation and suggest the deck successfully communicated the opportunity to professional investors.

What could have been stronger

Unclear fundraising ask and capital plan. The deck does not visibly specify the **exact amount being raised**, valuation, or detailed use‑of‑funds breakdown, making it harder for investors to assess capital requirements and planned allocation beyond high‑level growth ambitions.
Limited detail on traction quality and revenue mix. While the deck highlights that LucidAct already manages chronic care for 30,000 patients with 100 nurses and is transitioning from trials to revenue, it provides limited **granular traction data** such as cohort retention, churn, unit economics beyond per‑patient pricing, or breakdown between pilots and fully paid contracts.
Sparse regulatory and clinical validation information. The pitch heavily emphasizes AI assistance within the Medicare reimbursement landscape but offers little visible detail on **regulatory, compliance, and clinical validation** (e.g., HIPAA posture, clinical outcomes studies, or quality metrics), which are material risks in chronic care and RPM offerings.
High‑level market sizing but limited GTM detail. The deck appears to rely strongly on a large market size figure ($111B) with limited supporting **market segmentation and go‑to‑market strategy** specifics, such as targeted provider segments, sales cycle expectations, or customer acquisition channels, which are important for B2B healthcare SaaS and services.

How an investor would read this deck

What draws attention

Evidence that LucidAct was already managing chronic care for **30,000 patients** with **100 nurses** and charging **$44–$98 per patient per month**, suggesting early product‑market fit and a potentially attractive revenue base if these are paid contracts.
The focus on **Medicare and Medicaid chronic care programs** and workflow automation in a **$111B** market aligns with secular trends in value‑based care, RPM, and reimbursement‑driven chronic care management.
The combination of **AI‑driven workflows**, EMR and device integration, and nurse‑led virtual care suggests a hybrid tech‑plus‑services model that could be defensible if operational execution and data integration are strong.
Presence of recognized early‑stage healthcare and technology investors (Social Starts, 500, Liquid 2 Ventures, StartUp Health) provides external validation and may indicate prior diligence on the model and team.

Risks that stand out

Reliance on **Medicare and Medicaid reimbursement programs** and chronic care billing codes exposes the business to policy changes, documentation requirements, and payer audits that could materially impact revenue if workflows are not tightly aligned with regulations.
The hybrid **tech‑plus‑services model** with 100 nurses and large patient panels may have significant operational complexity; scaling such a model can stress quality control, margin, and consistency of care unless processes are highly standardized and automated.
Competitive pressure from other **digital health and RPM/CCM platforms** with stronger capitalization or established provider relationships could challenge LucidAct’s growth, especially if switching costs for providers are modest.
Publicly disclosed funding of only **$150K** suggests limited capital relative to the scale implied by 30,000 patients and 100 nurses, raising questions about sustainability, staffing model, and whether additional undisclosed funding or cash flow covers operations.

Questions this deck invites

Break down the **30,000 patients and 100 nurses** figures: how many are under long‑term contracts vs. pilots, and what proportion are reimbursed under Medicare CCM/RPM vs. other programs?
Provide **unit economics** per patient and per nurse: gross margin, average reimbursement per patient, contribution margin, and payback periods on customer acquisition given the $44–$98 per‑patient pricing.
Detail **regulatory and compliance posture**: HIPAA compliance, any FDA‑regulated components, and how LucidAct manages data security and privacy across EMR integrations and in‑home devices.
Share **clinical and operational outcome data**: reductions in ER visits or hospitalizations, adherence improvements, or quality metrics that validate the claimed benefits of AI‑driven chronic care management.
Clarify the **capital history and runway**: how the October 2019 $150K seed round and accelerator funding were deployed, current cash position, and future capital needs relative to scaling nurse operations and software development.

What founders can take from the LucidAct Health Inc deck

Early **operational traction metrics** (patients under management, size of nurse team, and per‑patient pricing) can make a seed‑stage deck more concrete and help investors understand revenue potential and scalability when presented clearly.
Positioning a product squarely within a complex **reimbursement landscape** (Medicare chronic care programs) is compelling when the deck explains how workflows and automation map to billing requirements and provider economics, not just technology features.
Demonstrating a combination of **AI technology and human services** (virtual care assistant plus nurse network) can differentiate a healthcare startup, but the deck should also preempt concerns about unit economics and operational scalability with data.
Large, headline **market size figures** (e.g., $111B) are more persuasive when accompanied by segmentation (target provider types, specific billing codes, and adoption pathways) that tie directly to the company’s current traction and pipeline.
Seed‑stage decks benefit from explicitly stating **funding ask, valuation, and use of proceeds**; leaving these implicit can create friction in investor conversations even when traction and product narrative are strong.
Including references or summaries of **clinical and outcome data** (hospitalization reduction, engagement metrics) would strengthen the case for chronic care management platforms and can be a differentiator compared with competitors that emphasize workflow automation alone.

LucidAct Health Inc pitch deck: common questions

What does LucidAct do?

LucidAct is a healthcare technology company that provides an AI‑powered chronic care management and remote care platform for healthcare organizations, including chronic care management (CCM), remote patient monitoring (RPM), insurance checklist automation, and virtual care workflows. Its system integrates EMR data, in‑home devices, and claims history to help care teams manage complex patients, reduce hospitalizations, and support value‑based care models.

When was LucidAct founded and where is it based?

According to CB Insights and PitchBook profiles, LucidAct was founded in **2015** and operates as a healthcare technology company in the United States. Public profiles list headquarters and office addresses in San Francisco and Santa Clara, California, indicating a San Francisco Bay Area base.

How much funding has LucidAct raised and who invested?

A company profile and funding databases report that LucidAct has raised **around $150K** in disclosed funding, categorized as a **seed round** completed on **October 3, 2019**, with the company described as "Generating Revenue" at that time. Investors listed include Social Starts, 500 Accelerator/500 Global, Liquid 2 Ventures, and StartUp Health.

What key metrics and business model did LucidAct highlight in its Batch 25 Demo Day pitch deck?

The Batch 25 Demo Day deck presents LucidAct’s AI assistant for chronic care management, highlighting that the company manages chronic care for **30,000 patients** using a team of **100 nurses**, and charges **$44–$98 per patient per month** on a subscription basis, targeting medium to large healthcare organizations in a **$111 billion** market. It positions the product as an AI assistant that automates workflows and supports Medicare reimbursement processes for chronic care programs.

What are LucidAct’s main products and features today, and how do they relate to the original pitch deck?

LucidAct’s platform offers pre‑built CCM workflows and forms, AI‑driven risk stratification, automated insurance eligibility checks, and tools for care teams to coordinate via calls, video, e‑fax, and email. The company continues to market an AI agent for care managers that automates outreach schedules, transcribes and summarizes calls into structured clinical notes, and supports referral matching and remote care programs for Medicare and Medicaid patients.